Adherence to the Dietary Approaches to Stop Hypertension (DASH) and risk of Nonalcoholic Fatty Liver Disease

International Journal of Food Sciences and Nutrition

Volumn 67, Issue 8, 2016, Pages 1024-1029

  Hekmatdoost, Azita ^a   Shamsipour, Ali ^a   Meibodi, Mohammad ^a   Gheibizadeh, Newsha ^a   Eslamparast, Tannaz ^a   Poustchi, Hossein ^b  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

case control; DASH diet; diet; Dietary Approaches to Stop Hypertension; fatty liver; NAFLD; NASH

Indexed keywords

ADULT; AGED; BODY MASS; CASE CONTROL STUDY; COMPLICATION; DASH DIET; DIET THERAPY; DYSLIPIDEMIA; FEMALE; HUMAN; MALE; MEDICAL RECORD; MIDDLE AGED; NONALCOHOLIC FATTY LIVER; OBESITY; PATIENT COMPLIANCE; RISK FACTOR;

ADULT; AGED; BODY MASS INDEX; CASE-CONTROL STUDIES; DIET RECORDS; DIETARY APPROACHES TO STOP HYPERTENSION; DYSLIPIDEMIAS; FEMALE; HUMANS; MALE; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; OBESITY; PATIENT COMPLIANCE; RISK FACTORS;

EID: 84978676879     PISSN: 09637486     EISSN: 14653478     Source Type: Journal    
DOI: 10.1080/09637486.2016.1210101     Document Type: Article

References (34)

1. F.Askari, B.Rashidkhani, A.Hekmatdoost 2014. Cinnamon may have therapeutic benefits on lipid profile, liver enzymes, insulin resistance, and high-sensitivity C-reactive protein in nonalcoholic fatty liver disease patients. Nutr Res. 34:143–148.
2. T.L.Barnes, J.L.Crandell, R.A.Bell, E.J.Mayer-Davis, D.Dabelea, A.D.Liese 2013. Change in DASH diet score and cardiovascular risk factors in youth with type 1 and type 2 diabetes mellitus:the SEARCH for Diabetes in Youth Study. Nutr Diabetes. 3:e91.
3. M.L.Bertoia, E.W.Triche, D.S.Michaud, A.Baylin, J.W.Hogan, M.L.Neuhouser, L.F.Tinker, L.Van Horn, M.E.Waring, W.Li, J.M.Shikany, C.B.Eaton. 2014. Mediterranean and Dietary Approaches to Stop Hypertension dietary patterns and risk of sudden cardiac death in postmenopausal women. Am J Clin Nutr. 99:344–351.
4. K.S.Collison, Z.Maqbool, S.M.Saleh, A.Inglis, N.J.Makhoul, R.Bakheet, M.Al-Johi, R.Al-Rabiah, M.Z.Zaidi, F.A.Al-Mohanna. 2009. Effect of dietary monosodium glutamate on trans fat-induced nonalcoholic fatty liver disease. J Lipid Res. 50:1521–1537.
5. H.E.Da Silva, B.M.Arendt, S.A.Noureldin, G.Therapondos, M.Guindi, J.P.Allard 2014. A cross-sectional study assessing dietary intake and physical activity in Canadian patients with nonalcoholic fatty liver disease vs healthy controls. J Acad Nutr Diet. 114:1181–1194.
6. M.J.Dekker, Q.Su, C.Baker, A.C.Rutledge, K.Adeli 2010. Fructose:a highly lipogenic nutrient implicated in insulin resistance, hepatic steatosis, and the metabolic syndrome. Am J Physiol Endocrinol Metab. 299:E685–E694.
7. F.H.Esfahani, G.Asghari, P.Mirmiran, F.Azizi 2010. Reproducibility and relative validity of food group intake in a food frequency questionnaire developed for the Tehran Lipid and Glucose Study. J Epidemiol. 20:150–158.
8. T.Eslamparast, S.Eghtesad, A.Hekmatdoost, H.Poustchi 2013. Probiotics and nonalcoholic fatty liver disease. Middle East J Dig Dis. 5:129–136.
9. T.Eslamparast, S.Eghtesad, H.Poustchi, A.Hekmatdoost 2015. Recent advances in dietary supplementation, in treating non-alcoholic fatty liver disease. World J Hepatol. 7:204–212.
10. T.Eslamparast, H.Poustchi, F.Zamani, M.Sharafkhah, R.Malekzadeh, A.Hekmatdoost 2014a. Synbiotic supplementation in nonalcoholic fatty liver disease:a randomized, double-blind, placebo-controlled pilot study. Am J Clin Nutr. 99:535–542.
11. T.Eslamparast, F.Zamani, A.Hekmatdoost, M.Sharafkhah, S.Eghtesad, R.Malekzadeh, H.Poustchi 2014b. Effects of synbiotic supplementation on insulin resistance in subjects with the metabolic syndrome:a randomised, double-blind, placebo-controlled pilot study. Br J Nutr. 112:438–445.
12. F.Faghihzadeh, P.Adibi, A.Hekmatdoost 2015. The effects of resveratrol supplementation on cardiovascular risk factors in patients with non-alcoholic fatty liver disease:a randomised, double-blind, placebo-controlled study. Br J Nutr. 114:796–803.
13. F.Faghihzadeh, P.Adibi, R.Rafiei, A.Hekmatdoost 2014. Resveratrol supplementation improves inflammatory biomarkers in patients with nonalcoholic fatty liver disease. Nutr Res. 34:837–843.
14. K.C.Fitzgerald, S.E.Chiuve, J.E.Buring, P.M.Ridker, R.J.Glynn 2012. Comparison of associations of adherence to a Dietary Approaches to Stop Hypertension (DASH)-style diet with risks of cardiovascular disease and venous thromboembolism. J Thromb Haemost. 10:189–198.
15. T.T.Fung, S.E.Chiuve, M.L.McCullough, K.M.Rexrode, G.Logroscino, F.B.Hu 2008. Adherence to a DASH-style diet and risk of coronary heart disease and stroke in women. Arch Intern Med. 168:713–720.
16. A.Ghaemi, F.A.Taleban, A.Hekmatdoost, A.Rafiei, V.Hosseini, Z.Amiri, R.Homayounfar, H.Fakheri 2013. How much weight loss is effective on nonalcoholic fatty liver disease? Hepat Mon. 13:e15227.
17. Z.Ghorbani, A.Hekmatdoost, P.Mirmiran 2014. Anti-hyperglycemic and insulin sensitizer effects of turmeric and its principle constituent curcumin. Int J Endocrinol Metab. 12:e18081.
18. V.Gupta, X.J.Mah, M.C.Garcia, C.Antonypillai, D.van der Poorten 2015. Oily fish, coffee and walnuts:dietary treatment for nonalcoholic fatty liver disease. World J Gastroenterol. 21:10621–10635.
19. R.Kelishadi, K.Rabiee, A.Khosravi, F.Famouri, M.Sadeghi, H.Rouhafza, S.ShiraniSh. 2001. Assessment of physical activity of adolescents in Isfahan. Shahrekord Univ Med Sci J. 3:55–66.
20. A.D.Liese, A.Bortsov, A.L.Gunther, D.Dabelea, K.Reynolds, D.A.Standiford, L.Liu, D.E.Williams, E.J.Mayer-Davis, R.B.J.D'AgostinoRB Jr, R.Bell, S.Marcovina. 2011. Association of DASH diet with cardiovascular risk factors in youth with diabetes mellitus:the SEARCH for Diabetes in Youth study. Circulation. 123:1410–1417.
21. A.D.Liese, M.Nichols, X.Sun, R.B.D’AgostinoJr., S.M.Haffner 2009. Adherence to the DASH Diet is inversely associated with incidence of type 2 diabetes:the insulin resistance atherosclerosis study. Diabetes Care. 32:1434–1436.
22. S.Nabavi, M.Rafraf, M.H.Somi, A.Homayouni-Rad, M.Asghari-Jafarabadi 2014. Effects of probiotic yogurt consumption on metabolic factors in individuals with nonalcoholic fatty liver disease. J Dairy Sci. 97:7386–7393.
23. W.H.Oddy, C.E.Herbison, P.Jacoby, G.L.Ambrosini, T.A.O’Sullivan, O.T.Ayonrinde, J.K.Olynyk, L.J.Black, L.J.Beilin, T.A.Mori, B.P.Hands, L.A.Adams. 2013. The Western dietary pattern is prospectively associated with nonalcoholic fatty liver disease in adolescence. Am J Gastroenterol. 108:778–785.
24. M.Rahimlou, H.Ahmadnia, A.Hekmatdoost 2015. Dietary supplements and pediatric non-alcoholic fatty liver disease:present and the future. World J Hepatol. 7:2597–2602.
25. M.E.Rinella 2015. Nonalcoholic fatty liver disease:a systematic review. JAMA. 313:2263–2273.
26. A.B.Ross, J.P.Godin, K.Minehira, J.P.Kirwan 2013. Increasing whole grain intake as part of prevention and treatment of nonalcoholic Fatty liver disease. Int J Endocrinol. 2013:585876
27. F.Salomone, J.Godos, S.Zelber-Sagi 2016. Natural antioxidants for non-alcoholic fatty liver disease:molecular targets and clinical perspectives. Liver Int. 36:5–20.
28. M.B.Schulze, J.E.Manson, D.S.Ludwig, G.A.Colditz, M.J.Stampfer, W.C.Willett, F.B.Hu 2004. Sugar-sweetened beverages, weight gain, and incidence of type 2 diabetes in young and middle-aged women. JAMA. 292:927–934.
29. E.A.Struijk, A.M.May, N.L.Wezenbeek, H.P.Fransen, S.S.Soedamah-Muthu, A.Geelen, J.M.Boer, Y.T.van der Schouw, H.B.Bueno-de-Mesquita, J.W.Beulens. 2014. Adherence to dietary guidelines and cardiovascular disease risk in the EPIC-NL cohort. Int J Cardiol. 176:354–359.
30. T.M.Vogt, L.J.Appel, E.Obarzanek, T.J.Moore, W.M.Vollmer, L.P.Svetkey, F.M.Sacks, G.A.Bray, J.A.Cutler, M.M.Windhauser, P.H.Lin, N.M.Karanja. 1999. Dietary Approaches to Stop Hypertension:rationale, design, and methods. DASH Collaborative Research Group. J Am Diet Assoc. 99:S12–S18.
31. K.Wijarnpreecha, C.Thongprayoon, P.J.Edmonds, W.Cheungpasitporn 2016. Associations of sugar- and artificially sweetened soda with nonalcoholic fatty liver disease:a systematic review and meta-analysis. QJM. 109:461–466.
32. W.Willett 2012. Nutritional epidemiology. New York:Oxford University Press.
33. Z.Yari, M.Rahimlou, T.Eslamparast, N.Ebrahimi-Daryani, H.Poustchi, A.Hekmatdoost 2016. Flaxseed supplementation in non-alcoholic fatty liver disease:a pilot randomized, open labeled, controlled study. Int J Food Sci Nutr. 67:461–469.
34. A.M.Zivkovic, J.B.German, A.J.Sanyal 2007. Comparative review of diets for the metabolic syndrome:implications for nonalcoholic fatty liver disease. Am J Clin Nutr. 86:285–300.